AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues. Its agonistic monoclonal antibody molecules stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune, and degenerative diseases.